Recursion Pharmaceuticals, Inc.
RXRX · NASDAQ
9/30/2025 | 6/30/2025 | 3/31/2025 | 12/31/2024 | |
|---|---|---|---|---|
| Assets | – | – | – | – |
| Cash & Equivalents | $659,836 | $528,216 | $500,453 | $594,350 |
| Short-Term Investments | $0 | $0 | $0 | $0 |
| Receivables | $21,910 | $21,606 | $46,124 | $49,166 |
| Inventory | $0 | $0 | $0 | $0 |
| Other Curr. Assets | $32,359 | $37,338 | $37,568 | $70,753 |
| Total Curr. Assets | $714,105 | $587,160 | $584,145 | $714,269 |
| Property Plant & Equip (Net) | $181,244 | $193,604 | $204,777 | $233,213 |
| Goodwill | $162,042 | $164,270 | $158,112 | $148,873 |
| Intangibles | $322,344 | $341,319 | $335,790 | $335,855 |
| Long-Term Investments | $0 | $5,629 | $0 | $0 |
| Tax Assets | $957 | $957 | $2,003 | $1,934 |
| Other NC Assets | $18,834 | $9,416 | $20,407 | $14,454 |
| Total NC Assets | $685,421 | $715,195 | $721,089 | $734,329 |
| Other Assets | $0 | $0 | $0 | $0 |
| Total Assets | $1,399,526 | $1,302,355 | $1,305,234 | $1,448,598 |
| Liabilities | – | – | – | – |
| Payables | $13,935 | $19,314 | $25,086 | $21,613 |
| Short-Term Debt | $20,444 | $8,752 | $20,440 | $8,425 |
| Tax Payable | $0 | $0 | $0 | $0 |
| Deferred Revenue | $47,364 | $39,690 | $39,651 | $61,767 |
| Other Curr. Liab. | $73,360 | $1,537 | $56,804 | $50,853 |
| Total Curr. Liab. | $155,103 | $164,026 | $141,981 | $187,472 |
| LT Debt | $61,930 | $14,196 | $72,470 | $19,022 |
| Deferred Rev, NC | $0 | $126,243 | $0 | $118,765 |
| Deferred Tax Liab, NC | $23,312 | $23,784 | $22,437 | $16,575 |
| Other NC Liab. | $112,233 | $1,565 | $134,399 | $4,732 |
| Total NC Liab. | $197,475 | $219,183 | $229,306 | $226,344 |
| Other Liabilities | $0 | $0 | $0 | $0 |
| Cap. Leases | $61,553 | $65,127 | $67,877 | $81,045 |
| Total Liabilities | $352,578 | $383,209 | $371,287 | $413,816 |
| Equity | – | – | – | – |
| Pref Stock | $0 | $0 | $0 | $0 |
| Common Stock | $5 | $4 | $4 | $4 |
| Retained Earnings | -$1,967,879 | -$1,805,589 | -$1,633,694 | -$1,431,283 |
| AOCI | $34,093 | $43,620 | $14,145 | -$7,637 |
| Other Equity | $2,980,729 | $0 | $2,553,492 | $0 |
| Total Equity | $1,046,948 | $919,146 | $933,947 | $1,034,782 |
| Supplemental Information | – | – | – | – |
| Minority Interest | $0 | $0 | $0 | $0 |
| Total Liab. & Tot. Equity | $1,399,526 | $1,302,355 | $1,305,234 | $1,448,598 |
| Net Debt | -$577,462 | -$505,268 | -$407,543 | -$566,903 |